These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7865106)

  • 1. Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR.
    Ghobrial II; Morris AG; Booth LJ
    Transpl Int; 1994; 7(6):420-7. PubMed ID: 7865106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.
    Bestard O; Cruzado JM; Mestre M; Caldés A; Bas J; Carrera M; Torras J; Rama I; Moreso F; Serón D; Grinyó JM
    J Immunol; 2007 Oct; 179(7):4901-9. PubMed ID: 17878390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of selective decline of donor-reactive IL-2-producing T lymphocytes after renal transplantation.
    Beik AI; Higgins RM; Lam FT; Morris AG
    Transpl Immunol; 1997 Jun; 5(2):89-96. PubMed ID: 9269030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that human cardiac allograft acceptance is associated with a decrease in donor-reactive helper T lymphocytes.
    DeBruyne LA; Renlund DG; Bishop DK
    Transplantation; 1995 Mar; 59(5):778-83. PubMed ID: 7886807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.
    Zhao Z; Yang C; Tang Q; Zhao T; Jia Y; Ma Z; Rong R; Xu M; Zhu T
    Transplant Proc; 2012 Dec; 44(10):2982-5. PubMed ID: 23195010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline Changes on Dysfunctional Renal Allograft Biopsies: Clinical Relevance in a Living Related Renal Transplant Setting.
    Mubarak M; Shakeel S; Abbas K; Aziz T; Zafar MN; Naqvi SA; Rizvi SA
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):24-27. PubMed ID: 28260426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.
    Shimizu A; Yamada K; Sachs DH; Colvin RB
    Kidney Int; 2000 Dec; 58(6):2546-58. PubMed ID: 11115090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.
    Rashid A; Sengar DP; Harris JE
    Clin Exp Immunol; 1979 Jun; 36(3):521-7. PubMed ID: 158449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute humoral rejection of renal allografts in CCR5(-/-) recipients.
    Bickerstaff A; Nozaki T; Wang JJ; Pelletier R; Hadley G; Nadasdy G; Nadasdy T; Fairchild RL
    Am J Transplant; 2008 Mar; 8(3):557-66. PubMed ID: 18294152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients.
    Böhmig GA; Säemann MD; Bergmann M; Watschinger B; Regele H; Windhager T; Mühlbacher F; Hörl WH; Zlabinger GJ
    Transpl Int; 2000; 13(3):187-93. PubMed ID: 10935701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
    Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
    Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique.
    Tanaka Y; Ohdan H; Onoe T; Mitsuta H; Tashiro H; Itamoto T; Asahara T
    Transplantation; 2005 May; 79(9):1262-7. PubMed ID: 15880082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
    Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.